Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1141 to 1155 of 1331 results for heart OR cardi* OR arrythmia

  1. Hypertension: confirming diagnosis with HBPM or ABPM (IND115)

    This indicator covers the percentage of patients with a new diagnosis of hypertension (diagnosed on or after 1 April 2014) which has been confirmed by ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) in the 3 months before entering on to the register. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM66

    General practice indicators suitable for use in QOF
    Last updated
    4 November 2020

  2. Virtual chromoendoscopy to assess colorectal polyps during colonoscopy (HTG438)

    Evidence-based recommendations on virtual chromoendoscopy (VCE) using NBI, FICE or i-scan to assess colorectal polyps of 5 mm or less during colonoscopy.

    HealthTech guidance
    Published
    10 May 2017

    Sections for HTG438

  3. Privacy notice

    How we collect and use your personal information, and your rights under data protection legislation.

  4. Mechanical thrombectomy devices for acute ischaemic stroke (MIB153)

    NICE has developed a medtech innovation briefing (MIB) on mechanical thrombectomy devices for acute ischaemic stroke .

    Medtech innovation briefing
    Published
    30 July 2018

  5. Is the application of antiseptics and antibiotics in the operative field before wound closure, clinically and cost effective in reducing surgical site infection rates?

    such as vancomycin, which is widely used worldwide and commonly used in cardiac, orthopaedic and spine surgery, suggested no reduction...

    Research recommendation
    Published
    16 August 2019

  6. What is the relative effectiveness and cost effectiveness of different oral fluids and different oral fluid regimens, both with and without oral N-acetylcysteine, at preventing contrast-induced acute kidney injury?

    medium or the healthcare professional offering the procedure, such as a cardiologist, would usually do this. For people with other...

    Research recommendation
    Published
    10 February 2020

  7. Early revascularisation strategy for people with angina and multivessel disease:- In people with stable angina and multivessel disease (including left main stem disease) whose symptoms are controlled with optimal drug treatment, would an initial treatment strategy of revascularisation be clinically and cost effective compared with continued drug treatment?

    have tests to identify whether they have a higher risk profile for early cardiac death, which could be reduced by revascularisation....

    Research recommendation
    Published
    9 June 2015

  8. Is the use of chlorhexidine body wash associated with increased antimicrobial resistance?

    cause of a surgical site infection. The committee agreed that although cardiac and orthopaedic surgery can be considered high risk,...

    Research recommendation
    Published
    16 August 2019

  9. Evidence on the efficacy of bioresorbable stent implantation to treat coronary artery disease is inadequate. Evidence on its safety has shown an increased risk of serious complications in the longer term. This includes an increased risk of myocardial infarction and death with some types of bioresorbable stents. Therefore, this procedure should only be used in the context of research. Find out what only in research means on the NICE interventional procedures guidance page.

    implantation to treat coronary artery disease into the National Institute for Cardiovascular Outcomes Research's National Audit of...

    Research recommendation
    Published
    7 September 2022

  10. What is the effectivness of statin treatment in older people?

    effects. Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    3 May 2024

  11. Automated blood pressure monitoring in people with atrial fibrillation: Which automated blood pressure monitors are suitable for people with hypertension and atrial fibrillation?

    on monitoring treatment and blood pressure targets for people without cardiovascular disease. Full details of the evidence and the...

    Research recommendation
    Published
    11 April 2022

  12. Can risk of contrast-induced acute kidney injury be stratified by eGFR thresholds?

    medium or the healthcare professional offering the procedure, such as a cardiologist, would usually do this. For people with other...

    Research recommendation
    Published
    10 February 2020

  13. What is the most accurate prenatal screening marker for TAPS, including middle cerebral artery peak systolic velocity (MCA‑PSV)?

    umbilical artery and ductus venosus doppler parameters, or signs of fetal cardiac failure in the anaemic baby. These can also occur in a...

    Research recommendation
    Published
    8 November 2019

  14. What is the effectiveness of age alone and other routinely available risk factors compared with the formal structured multifactorial risk assessment to identify people at high risk of developing CVD?

    effects . Source guidance details Comes from guidance Cardiovascular disease: risk assessment and reduction, including lipid modification

    Research recommendation
    Published
    3 May 2024

  15. What is the most clinically and cost-effective timing and dose of a single administration of gabapentin to relieve pain in people undergoing surgery whose pain is expected to be moderate to severe?

    fewer side effects from opioid consumption. NSAIDs Concerns about cardiac and renal complications have limited the use of NSAIDs in...

    Research recommendation
    Published
    26 October 2020